Coronavirus digest: Steinmeier says vaccination start a day of hope as EU approves use
The German president called getting vaccinated an act of solidarity. Meanwhile, EMA approved use of the BioNTech-Pfizer vaccine as a new strain of COVID-19 in the UK has led to travel bans. Follow DW for the latest.
German President Steinmeier called on Germans to get vaccinated as an act of solidarity with all of humanity
German President Frank-Walter Steinmeier on Monday said the introduction of the newly approved BioNTech-Pfizer coronavirus vaccination would be a day of hope and told citizens that getting inoculated against the deadly virus was an act of solidarity with all of humanity. Steinmeier said broad immunization was needed to stop the spread of a virus that has killed more than 20,000 people in Germany with 10,000 dying in the first three weeks of December alone. He added that the government has no plans for compulsory immunization.
Qatar, Oman to receive Pfizer-BioNTech COVID-19 vaccine this week - Region - World
ahram.org.eg - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ahram.org.eg Daily Mail and Mail on Sunday newspapers.
Coronavirus digest: Countries impose UK travel ban, EU awaits vaccine approval | News | DW
dw.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dw.com Daily Mail and Mail on Sunday newspapers.
21 Dec 2020 / 18:52 H.
(Updates with developments)
Dec 21 (Reuters) - Britain stood shut off from the rest of Europe on Monday after allies cut transport ties over fears of a new coronavirus strain, sowing chaos for families, truckers and supermarkets just days before the Brexit cliff edge.
DEATHS AND INFECTIONS Eikon users, see COVID-19: MacroVitals https://apac1.apps.cp.thomsonreuters.com/cms/?navid=1592404098 for a case tracker and summary of news.
EUROPE Europe s medicines regulator will on Monday assess the COVID-19 vaccine jointly developed by U.S. company Pfizer and its German partner BioNTech, with a green light putting Europe on course to start inoculations within a week.